Barclays raised the firm’s price target on Marriott to $189 from $188 and keeps an Equal Weight rating on the shares. The analyst expects Q2 lodging earnings reports to be in-line to slightly better than estimates, with decelerating trends in the U.S offset by strength from abroad. The firm prefers Hilton (HLT) for its exposure to the best domestic RevPAR growth segments and its “best-in-class” organic unit growth story heading into a lower RevPAR growth environment.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MAR:
- Marriott license agreement with MGM an incremental positive, says Baird
- Marriott, MGM Resorts announce long-term license agreement
- Marriott price target raised to $208 from $201 at Morgan Stanley
- Marriott is sued by guests over employee-protection surcharge, WSJ reports
- Marriott commits to hiring more than 3,000 refugees globally by 2026